GENEVA : The World Health Organization (WHO) announced on Wednesday that it will soon test three drugs used for other diseases to find out if they can help patients with coronavirus.
The UN Public Health Agency said in a statement today that the three drugs would be included in the next phase of the current global study of potential treatments for COVID-19.
The drugs were selected by an independent commission based on the likelihood that they could prevent deaths in people hospitalized for coronavirus.
Read More
- Colombia earthquake death toll rises to 294 as rescue hopes fade
- Oman negotiations, reopening of Hormuz are two separate issues: Iranian FM Araghchi
- At least 47 killed, 157 homes damaged as Indonesia reels from devastation after three earthquakes
- H-1B visa extension fee unlikely to outweigh cost of losing skilled talent
- No decision yet on US talks, Iran says as Hormuz tensions rise
These include artesunate, a malaria drug, the cancer drug imatinib, and infliximab, which is currently used in people with immune system disease.
The current WHO study on COVID-19 treatments previously included four drugs. Among the findings, the agency found that remdesivir and hydroxychloroquine did not help people hospitalized for coronavirus. The WHO survey includes thousands of investigators in hundreds of hospitals in 52 countries.
“Finding more effective and affordable drugs for patients with COVID-19 remains crucial,” said WHO Director-General Tedros Adhanom Ghebreyesus. (ANI/FENA)
